donde la salud pública y la se encuentran Salud publica€¦ · ZUBAIR ANSARI 9:15 to 9:30 In favor of Phacoemulsification University of Manitoba, Canada (teleconference) DR. GUILLERMO

8:15 to 8:35

8:00 to 8:15

The ophthalmologist of the future: The need to modernize training programs and methodologies

Welcome and Inauguration

DR. JORGE E VALDEZ

8.35 to 8.45Fostering International Research Collaborations to Prevent and Manage Eye Disease

Health Attaché of the US Embassy in Mexico CityDR. MARÍA JULIA MARINISSEN

8.45 to 9:05How to develop effective models for cooperation in global ophthalmology

Bascom Palmer, Miami, USA (in-person)

DR. ZUBAIR ANSARI

Dean of the Faculty of Health Sciences of ITESM (Instituto Tecnológico de Estudios Superiores de Monterrey)

President, Centro Mexicano de Salud Visual Preventiva [Mexican Center for Preventive Visual Health of the Mexican

Society of Ophthalmology] and Head of the Glaucoma Department of APEC (Asociación Para Evitar la Ceguera en

México). *President, Sociedad Mexicana de Oftalmología [Mexican Society of Ophthalmology]

II. INTERNATIONAL COURSE ON VISUAL HEALTH The Intersection Between Public Health and Science

February 14 and 15, 2020 UNAM Juriquilla, Querétaro

February 14, 7:30 to 9:05 a.m

for both general and highly specializedIntermediate/advanced level courseophthalmologists

Objectives: 1. Provide epidemiological data on the main causes of visual disability.

2. Discuss the benefits of multi-disciplinary and comprehensive case management.

3. Emphasize the importance of early detection and referral of these pathologies.

4. Explore the benefits of telemedicine and artificial intelligence resources.

5. Highlight the value of visual rehabilitation.

7:30: REGISTRATION

Saludpublica

II CURSO INTERNACIONAL DE SALUD VISUAL

donde la salud pública y la ciencia se encuentran

DR. JESÚS JIMÉNEZ ROMÁNAND DR. CLAUDIA PALACIO

20 min.

10 min.

20 min.

9:05 to 9:15Epidemiology Invasive vs. pharmaceu-tical management of early-stage PAOG

DR. SERGE RESNIKOFF

9:15 to 9:30Conservative management

University of Cambridge, England (teleconference)DR. RUPERT BOURNE

9:30 to 9:45Early surgical intervention

9:45 to 10:00The use of telemedicine in glaucoma

Colombia (in-person) Universidad del Bosque, Bogota, Colombia

DR. JUAN CARLOS RUEDA

10 min.

15 min.

DISCUSSION30 min.

15 min.

15 min.

Brien Holden Vision Institute (BHVI), Geneva, Switzerland (in-person)

10:00 to 10:30

CONCLUSIONS5 min.

10:45 to 10:55

QUESTION AND ANSWER PERIOD15 min.

10:30 to 10:45

Saludpublica



BREAK 10:55 to 11:20

90 min. Glaucoma Module Coordinator: Dr. Jesús Jiménez - Román

Sub coordinators: Dr. Ellery M. López - Star, Dra. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Francisco Martínez Castro

Commentator: Dr. Karla Dueñas, Dra. Alejandra Hernández de Oteiza

Objectives: Review the current global epidemiological status of glaucoma.

Compare the use of anti-glaucoma medications versus early surgery.

Emphasize the importance of conservative management.

Consider distance management as a public policy alternative.

11:45 to 12:00What are the repercussions of amblyopia in the community?

11:20 to 11:30Epidemiology

DR. SERGE RESNIKOFF

11:30 to 11:45Amblyopia and the management of external programs for childrenUniversity of Arizona, Tucson, USA (in-person)

DR. JOE MILLER

Brazil, PAAO Low Vision Society (in-person)DR. LUCIENE FERNÁNDEZ

10 min.

15 min.

DISCUSSION20 min.

15 min.

Centro Mexicano para Visión Baja [Mexican Center for Low Vision] (in-person)

DR. ANA MARÍA BEAUREGARParticipant in the discussion


12:00 to 12:20

CONCLUSIONS5 min.

12:35 to 12:40


12:20 to 12:30

Saludpublica



75 min. Refractive Errors Coordinator: Dr. Bethania López – Star

Sub coordinators: Dr. Ellery M. López - Star, Dra. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román, Dr. Francisco Martínez Castro

Commentator: Dr. Sandra Villegas, Dr. Ana María Beauregard, Lourdes Medina

Objectives: Understand the epidemiology.

Emphasize the importance of early detection and correction.

Identify the variables of amblyopia.

Understand the negative impact of a late diagnosis.

13:20 to 13:35Using artificial intelligence

12:40 to 12:50Epidemiology of diabetic retinopathy Detection of DR: artificial intelligence vs. manual assessment via telemedicine

DR. SERGE RESNIKOFF

13:05 to 13:20Manual assessmen

13:35 to 13:50The use of Anti-VEGF vs. Ozurdex

University of Queens, Ireland (in-person)DR. TUNDE PETO

Barranquilla, Colombia (in person) Universidad del Bosque, Bogota, Colombia

DR. JUAN CARLOS RUEDA

10 min.

15 min.

University of Queens, Ireland (in-person)DR. TUNDE PETO

15 min.

DISCUSSION30 min.

15 min.


13:50 to 14:20

CONCLUSIONS5 min.

14:30 to 14:35


14:20 to 14:30

Saludpublica



100 min. Diabetic Retinopathy Module Coordinator: Dr. Marlon García – Roa

Commentators: Dr. Marco Vinicio García, Dr. Yolanda Villalpando

Sub coordinators: Dr. Ellery M. López - Star, Dra. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román, Dr. Francisco Martínez Castro, Dr. Miguel Vázquez Membrillo


Evaluate the advantages and disadvantages of telemedicine in detecting diabetic retinopathy, either manually or with the use of artificial intelligence.

Identify the ideal patient for management with Anti-VEGF or intravitreal corticosteroids in the treatment of diabetic macular edema.

BANQUET 14:35 to 15:45


Evaluate the advantages and disadvantages of telemedicine in detecting diabetic retinopathy, either manually or with the use of artificial intelligence.

Identify the ideal patient for management with Anti-VEGF or intravitreal corticosteroids in the treatment of diabetic macular edema.

16:10 to 16:25Anti-angiogenics as monotherapy: breaking the paradigm

15:45 to 15:55Epidemiology of ROP. Pros and cons of anti-angiogenics in ROP

DR. CLARE GILBERT

15:55 to 16:10The current state of laser therapy as a gold standard

16:25 to 16:40When and how to combine both options

LSTHM, University of London, England (teleconference)DR. CLARE GILBERT

University of California, San Francisco, USA (teleconference)

DR. ALEJANDRA DE ALBA

10 min.

15 min.

BOTH PRESENTERS15 min.

DISCUSSION30 min.

15 min.

LSTHM, University of London, England (teleconference)

16.40 to 17:10

CONCLUSIONS5 min.

17:20 to 17:25


17:10 to 17:20

Saludpublica



Objectives: Understand the epidemiology. Outline current therapeutic criteria and the present and future role of anti-angiogenics.

105 min. Retinopathy of Prematurity (ROP)Coordinator: Dr. Fernando Pérez Pérez

Commentators: Dr. Maria Mayorga Castellanos, Dr. Martha Griselda Rangel Charqueño

Sub coordinators: Dr. Ellery M. López - Star, Dra. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román, Dr. Francisco Martínez Castro, Dr. Paulina Ramírez Neria

17:20 to 17:30Epidemiology of visual disability

DR. SERGE RESNIKOFF

17:30 to 17:45Strategies to integrate health profes-sionals into visual rehabilitation Brazil, PAAO Low Vision Society (in-person)

DR. LUCIENE FERNÁNDEZ

17:45 to 18:00Challenges for the ophthalmologist Centro Mexicano para Visión Baja [Mexican Center for

Low Vision] (in-person)

DR. ANA MARÍA BEAUREGAR

10 min.

15 min.

DISCUSSION15 min.

15 min.


75 min Low Vision Module


Recognize the importance of early detection and referral of low vision.

Share experiences to generate a culture of visual rehabilitation.

Understand the challenges facing ophthalmologists in the area of low vision.

18:00 to 18:15

CONCLUSIONS5 min.

18:30 to 18:35


18:15 to 18:30

Saludpublica



Coordinator: Dr. Francisco Martínez – Castro

Sub coordinators: Dr. Ellery M. López - Star, Dr. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román

Commentator: Dr. Roxana Urdapilleta

Epidemiology. What type of IOL and surgical procedure would you choose for yourself as an ophthalmologist?

Epidemiology. What type of IOL and surgical procedure would you choose for yourself as an ophthalmologist?

Saludpublica



DR. SERGE RESNIKOFF

7:40 to 7:55

University of Manitoba, Canada (teleconference)DR. GUILLERMO ROCHA

7:55 to 8:10Bascom Palmer, Miami, USA (in-person)DR. GUILLERMO AMESCUA

10 min.

15 min.

DISCUSSION20 min.

15 min.


8:10 to 8:30

CONCLUSIONS5 min.

8:40 to 8:45


8:30 to 8:40

Coordinator: Dr. Jaime Macias

Sub coordinators: Dr. Ellery M. López - Star, Dr. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román, Dr. Francisco Martínez Castro, Dr. Pamela González Daher, Dr. Juan Pablo Olivares

Commentator: Dra. Azyadeth Camacho, Dra. Cristina Mendoza

II. INTERNATIONAL COURSE ON VISUAL HEALTH The Intersection Between Public Health and Science

February 14 and 15, 2020 UNAM Juriquilla, Querétaro

February 15, 7:30 am

65 min. Cataract I


Identify the best cost/benefit options in cataract surgery.

Share perspectives on the advantages and disadvantages of currently available options in cataract surgery.

7:30 to 7:40Epidemiology. What type of IOL and surgical procedure would you choose for yourself as an ophthalmologist?

Saludpublica



Objectives:

To understand: • The prevalence of cataract in Mexico: is it the result of limited access to cataract surgery? • From the economic point of view: the difference between Phacoemulsification and MSICS • Visual results achieved with MSICS • Cases in which each technique offers greater benefits

90 min. Cataract IICoordinator: Dr. Sandra de la Cruz

Sub coordinators: Dr. Ellery M. López Star, Dr. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román, Dr. Francisco Martínez Castro, Dr. Pamela González Daher

Commentator: Dra. Azyadeth Camacho, Dra. Cristina Mendoza

Phacoemulsification vs. MSICS

8:45 to 9:00

DR. GUILLERMO AMESCUA

9:00 to 9:15

In favor of MSICS Bascom Palmer, Miami, USA (in-person)DR. ZUBAIR ANSARI

9:15 to 9:30

In favor of PhacoemulsificationUniversity of Manitoba, Canada (teleconference)

DR. GUILLERMO ROCHA

15 min.

15 min.

DISCUSSION20 min.

15 min.

Bascom Palmer, Miami, USA (in-person)

9:30 to 9:50

CONCLUSIONS5 min.

10:00 to 10:05


9:50 to 10:00

BREAK 10:05 to 10:35

How to combine both techniques in practice

Saludpublica



Objectives: This module is aimed at exploring the current role of surgical simulators in resident training, as well as examining the advantages of incorporating them into the curriculum.

60 min. Surgical SimulatorsCoordinator: Dr. Juan Alberto López Ulloa

Sub coordinators: Dr. Ellery M. López - Star, Dr. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román, Dr. Francisco Martínez Castro, Dr. Pamela González Daher

Commentator: Dr. Francisco Alvarado

DR. DANIEL HUTTER

10:50 to 11:05Simulators for Phacoemulsification and vitreoretinal surgeryBascom Palmer, Miami, USA (in-person)

DR. ZUBAIR ANSARI

15 min.

15 min.

DISCUSSION15 min.

Bascom Palmer, Miami, USA Help Me See (in-person)

11:05 to 11:20

CONCLUSIONS5 min.

11:30 to 11:35


11:20 to 11:30

10:35 to 10:50Simulators for MSICS (Manual Small Incision Cataract Surgery) and OIDC (Ocular Incisions and Dissections Course)

Saludpublica



Objectives: Understand the current epidemiology of patients with keratoconus, as well as the various therapeutic options patients in early stages of the condition. Identify the existing keratoplasty options for cases of keratoconus.

70 min. Cornea: Keratoconus Coordinator: Dr. Diana Álvarez – Melloni

Sub coordinators: Dr. Ellery M. López - Star, Dra. Victoria Castañeda, Dr. Van C. Lansingh, Dr. Jesús Jiménez Román, Dr. Francisco Martínez Castro, Dr. Bethania López – Star, Dr. Diana Álvarez - Melloni

Commentator: Andrew Olivo, Alejandro Litchinger

11:35 to 11:45Epidemiology

DR. SERGE RESNIKOFF

11:45 to 12:00Early management and treatment options for keratoconus

University of Manitoba, Canada (teleconference)DR. GUILLERMO ROCHA

12:00 to 12:15Keratoplasty alternatives Bascom Palmer, Miami, USA (in-person)

DR. GUILLERMO AMESCUA

10 min.

15 min.

DISCUSSION15 min.

15 min.

BHVI, Geneva, Switzerland

12:15 to 12:30

CONCLUSIONS5 min.

12:40 to 12:45


12:30 to 12:40

12:45 to 13:15 Keynote Speech: What the world needs in terms of the training and numbers of future ophthalmologists

Dr. Serge Resnikoff, BHVI. Geneva, Switzerland

13:15 to 14:15 Conclusion and preparation of report and suggestions

BANQUET 14:35 to 15:45

Documents

donde la salud pública y la se encuentran Salud publica€¦ · ZUBAIR ANSARI 9:15 to 9:30 In favor of Phacoemulsification University of Manitoba, Canada (teleconference) DR. GUILLERMO